Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Jun Zhou, Wenhan Huang, Feifeng Ren, Lei Luo, Dongmei Huang & Lin Tang. (2021) Evaluation of Prognostic Factors in Anti-MDA5 Antibody-Positive Patients in Chongqing, China: A Retrospective Study. International Journal of General Medicine 14, pages 4775-4781.
Read now
Read now
Y-Z Jin, M-S Xie, C Yang, R-L Wu, Y-B Zhou & X-M Li. (2021) Prognostic value of peripheral blood markers in patients with myositis-associated interstitial lung diseases. Scandinavian Journal of Rheumatology 50:3, pages 218-226.
Read now
Read now
Noriko Sasaki, Akira Ishii, Takayoshi Kurabayashi, Mai Sugiyama, Yuto Izumi, Yoko Nakagome, Kazuki Hirano, Sho Sasaki, Yasushi Kondo, Shinichi Nogi, Ayumi Nishikawa, Yuji Hosono, Chiho Yamada & Shinji Sato. (2021) Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease. Modern Rheumatology Case Reports 5:1, pages 87-94.
Read now
Read now
Shin-ichiro Ohmura, Toru Yamabe & Taio Naniwa. (2021) Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies. Modern Rheumatology Case Reports 5:1, pages 76-81.
Read now
Read now
Koichi Yamaguchi, Aya Yamaguchi, Yuji Onuki, Miki Itai, Chiharu Kashiwagi, Kazutaka Takehara, Shuhei Aoki, Azusa Kanaya, Kohei Taguchi, Kazue Umetsu, Kazuma Oshima, Megumi Uchida, Hayato Kimura, Morimitsu Kasahara, Masao Takemura, Kenichiro Hara, Akiko Sekiguchi, Sei-ichiro Motegi, Yoshinao Muro, Masao Nakasatomi, Rena Motohashi, Toru Sakairi, Junichi Nakagawa, Keiju Hiromura, Masaru Obokata, Masahiko Kurabayashi & Toshitaka Maeno. (2021) Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age. Modern Rheumatology 31:1, pages 177-185.
Read now
Read now
Ran Nakashima. (2018) Clinical significance of myositis-specific autoantibodies. Immunological Medicine 41:3, pages 103-112.
Read now
Read now
Articles from other publishers (55)
Kenichiro Hata, Takuya Kotani, Shogo Matsuda, Youhei Fujiki, Takayasu Suzuka, Takao Kiboshi, Yumiko Wada, Hideyuki Shiba, Takeshi Shoda, Maki Kagitani & Tohru Takeuchi. (2023) Aggressive multi‐combination therapy for anti‐MDA5 antibody‐positive dermatomyositis‐rapidly progressive interstitial lung disease. International Journal of Rheumatic Diseases.
Crossref
Crossref
Jieting Jia, Defang Meng, Xuexiang Zhang, Nalin Lai, Beibei Zhou, Hua Wei & Xiaocong Li. (2023) Clinical application of blood purification in polymyositis/dermatomyositis. Therapeutic Apheresis and Dialysis.
Crossref
Crossref
Shuangjun He, Yuhong Zhou, Chenyu Fan, Jun Ma, Yi Chen, Wanlong Wu & Xingyu Zhang. (2023) Differences in sex- and age-associated mortality in patients with anti-MDA5-positive dermatomyositis. Modern Rheumatology 33:5, pages 975-981.
Crossref
Crossref
Shuhua Wang, Yao Li, Yanchun Tang, Weilin Xie, Yue Zhang & Qingyan Liu. (2023) A prospective observational cohort study of the efficacy of tofacitinib plus iguratimod on rheumatoid arthritis with usual interstitial pneumonia. Frontiers in Immunology 14.
Crossref
Crossref
Lijun Liu, Yinli Zhang, Cong Wang, Wenjuan Guan, Xin Zhang, Lei Zhang, Yujie He, Wenlu Hu, Shengyun Liu & Tianfang Li. (2023) Ground-glass opacity score predicts the prognosis of anti-MDA5 positive dermatomyositis: a single-centre cohort study. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Julio Alejandro Cerna-López, Paul J. Tejada-Llacsa, Fiorella Andrea de Jesús Valle-Farfán, Graciela S. Alarcón, Manuel F. Ugarte-Gil & Víctor R. Pimentel-Quiroz. (2023) Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review. Revista Colombiana de Reumatología (English Edition) 30:3, pages 277-282.
Crossref
Crossref
Julio Alejandro Cerna-López, Paul J. Tejada-Llacsa, Fiorella Andrea de Jesús Valle-Farfán, Graciela S. Alarcón, Manuel F. Ugarte-Gil & Víctor R. Pimentel-Quiroz. (2023) Rapidly progressive interstitial lung disease-associated hypomyopathic dermatomyositis complicated with pneumomediastinum: A case-based review. Revista Colombiana de Reumatología 30:3, pages 277-282.
Crossref
Crossref
Yanhua Wang, Jing Luo, Xiaohong Lv, Yuanyuan Li, Qi An, Lingfei Mo, Nan Hu, Jing Zhang, Jing Wang, Juan Tian, Dan Pu, Zhiming Hao & Lan He. (2023) Tofacitinib for new-onset adult patients with anti-melanoma differentiation-associated 5 gene antibody positive dermatomyositis. Clinical Rheumatology 42:7, pages 1847-1853.
Crossref
Crossref
Baolu Yang, Suying Liu, Zhenbei Qian & Zhaohui Tong. (2023) Predicting the death of patients with anti-melanoma differentiation–associated protein-5-positive dermatomyositis-associated interstitial lung disease: A systematic review and meta-analysis. Modern Rheumatology.
Crossref
Crossref
Xinyue Lian, Yan Ye, Jing Zou, Chunmei Wu, Shuang Ye, Qiang Guo, Sheng Chen, Liangjing Lu, Ran Wang, Qiong Fu & Chunde Bao. (2023) Longitudinal study of patients with antimelanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated interstitial lung disease. Rheumatology 62:5, pages 1910-1919.
Crossref
Crossref
Qiwen Jin, Lijun Fu, Hongxia Yang, Xixia Chen, Sang Lin, Zhenguo Huang, Baoxiang Gao, Xiaolan Tian, Wei Jiang, Xiaoming Shu, Xin Lu, Guochun Wang & Qinglin Peng. (2023) Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis. Journal of Internal Medicine 293:4, pages 494-507.
Crossref
Crossref
Maki Kagitani, Hayahito Nomi & Haruhito Azuma. (2022) Clinical parameters of therapeutic apheresis induction in clinically amyopathic dermatomyositis patients with rapid progressive interstitial lung disease. Therapeutic Apheresis and Dialysis 27:1, pages 152-158.
Crossref
Crossref
Theodoros Karampitsakos, Vasilios Tzilas, Ourania Papaioannou, Serafeim Chrysikos, Eirini Vasarmidi, Pierre-Antoine Juge, Styliani Vizirianaki, Eleni Bibaki, Argyro Reppa, Prodromos Sidiropoulos, Matthaios Katsaras, Vasilina Sotiropoulou, Panagiota Tsiri, Electra Koulousousa, Eva Theochari, Georgios Tsirikos, Ioannis Christopoulos, Elli Malakounidou, Eirini Zarkadi, Fotios Sampsonas, Georgios Hillas, Theofanis Karageorgas, Dimitrios Daoussis, Christina Kalogeropoulou, Katerina Dimakou, Nikolaos Tzanakis, Raphael Borie, Philippe Dieudé, Katerina Antoniou, Bruno Crestani, Demosthenes Bouros & Argyris Tzouvelekis. (2023) Clinical features and outcomes of patients with myositis associated-interstitial lung disease. Frontiers in Medicine 9.
Crossref
Crossref
Ujjwol Risal, Suravi Pandey, Raju Pangeni, Rakshya Pandey, Dharmagat Bhattarai, Sudeep Adhikari & Buddha Basnyat. (2023) Case Report: Anti-MDA-5 dermatomyositis in a resource-limited setting. Wellcome Open Research 8, pages 5.
Crossref
Crossref
Xiaomeng Li, Yongmei Liu, Linlin Cheng, Yuan Huang, Songxin Yan, Haolong Li, Haoting Zhan & Yongzhe Li. (2022)
Roles of biomarkers in
anti‐MDA5
‐positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease
. Journal of Clinical Laboratory Analysis 36:11.
Crossref
Crossref
Shogo Matsuda, Takuya Kotani & Tohru Takeuchi. (2022) Comment on: Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation–associated gene 5–positive dermatomyositis. Rheumatology 61:9, pages e282-e283.
Crossref
Crossref
Tao Liu, Wen Li, Zehao Zhang, Ting Jiang, Yu Fei, Jing Huang & Qibing Xie. (2022) Neutrophil-to-lymphocyte ratio is a predictive marker for anti-MDA5 positive dermatomyositis. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Qiuhe Chen & Long Qian. (2022) Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity. Contrast Media & Molecular Imaging 2022, pages 1-6.
Crossref
Crossref
Qian Niu, Li-qin Zhao, Wan-li Ma, Liang Xiong, Xiao-rong Wang, Xin-liang He & Fan Yu. (2022) A New Predictive Model for the Prognosis of MDA5+ DM-ILD. Frontiers in Medicine 9.
Crossref
Crossref
Koichi Yamaguchi, Takahito Nakajima, Aya Yamaguchi, Miki Itai, Yuji Onuki, Yuki Shin, Shogo Uno, Sohei Muto, Shunichi Kouno, Masakiyo Yatomi, Haruka Aoki-Saito, Kenichiro Hara, Yukie Endo, Sei-ichiro Motegi, Yoshinao Muro, Masao Nakasatomi, Toru Sakairi, Keiju Hiromura, Natsumi Katsumata, Hiromi Hirasawa, Yoshito Tsushima & Toshitaka Maeno. (2022) Quantitative CT analysis of interstitial pneumonia in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: a single center, retrospective study. Clinical Rheumatology 41:5, pages 1473-1481.
Crossref
Crossref
Koichi Yamaguchi, Yasuhiro Fukushima, Aya Yamaguchi, Miki Itai, Yuki Shin, Shogo Uno, Sohei Muto, Shunichi Kouno, Hiroaki Tsurumaki, Masakiyo Yatomi, Haruka Aoki-Saito, Kenichiro Hara, Yasuhiko Koga, Noriaki Sunaga, Yukie Endo, Sei-ichiro Motegi, Masao Nakasatomi, Toru Sakairi, Hidekazu Ikeuchi, Keiju Hiromura, Takeshi Hisada, Yoshito Tsushima, Masataka Kuwana & Toshitaka Maeno. (2022) Influence of obesity in interstitial lung disease associated with anti-aminoacyl-tRNA synthetase antibodies. Respiratory Medicine 193, pages 106741.
Crossref
Crossref
Albert Selva-O'Callaghan & Ernesto Trallero-Araguás. 2022. The Lung in Autoimmune Diseases. The Lung in Autoimmune Diseases
105
151
.
Yueyan Lou, Qing Wei, Bijun Fan, Liyan Zhang, Xiaodong Wang, Zhiwei Chen, Xiaoming Tan & Yu Zheng. (2021) The composition of the lung microbiome differs between patients with dermatomyositis and rheumatoid arthritis associated with interstitial lung disease. FEBS Open Bio 12:1, pages 258-269.
Crossref
Crossref
Wanlong Wu, Wenwen Xu, Wenjia Sun, Danting Zhang, Jiangfeng Zhao, Qun Luo, Xiaodong Wang, Feng Zhu, Yu Zheng, Yu Xue, Weiguo Wan, Huaxiang Wu, Qian Han & Shuang Ye. (2022) Forced vital capacity predicts the survival of interstitial lung disease in anti-MDA5 positive dermatomyositis: a multi-centre cohort study. Rheumatology 61:1, pages 230-239.
Crossref
Crossref
Qihua Yang, Tianfang Li, Xin Zhang, Kunlong Lyu, Shujun Wu, Yan Chen, Shengyun Liu & Zujiang Yu. (2021) Initial predictors for short-term prognosis in anti-melanoma differentiation-associated protein-5 positive patients. Orphanet Journal of Rare Diseases 16:1.
Crossref
Crossref
Wenwen Xu, Wanlong Wu, Danting Zhang, Zhiwei Chen, Xinwei Tao, Jiangfeng Zhao, Kaiwen Wang, Xiaodong Wang, Yu Zheng & Shuang Ye. (2021) A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Scientific Reports 11:1.
Crossref
Crossref
Chih-Wei Tseng, Kao-Lun Wang, Pin-Kuei Fu, Cheng-Yi Huang, Tsu-Yi Hsieh, Chia-Wei Hsieh, Kuo-Lung Lai, Wei-Ting Hung, Ching-Tsai Lin, Kuo-Tung Tang, Yi-Ming Chen, Wen-Nan Huang & Yi-Hsing Chen. (2021) GAP Score and CA-153 Associated with One-Year Mortality in Anti-MDA-5 Antibody-Positive Patients: A Real-World Experience. Journal of Clinical Medicine 10:22, pages 5241.
Crossref
Crossref
Anaïs Nombel, Nicole Fabien & Frédéric Coutant. (2021) Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies. Frontiers in Immunology 12.
Crossref
Crossref
Changjian Wang, Jinfeng Du, Xilong Mei, Lingchao Guo, Fangzhao Li, Hong Luo & Fen Li. (2021) The Value of Effective Lung Ventilation Area Ratio Based on CT Image Analysis Is a New Index to Predict the Shorter Outcome of Anti-melanoma Differentiation-Associated Protein 5 Positive Dermatomyositis Associated Interstitial Lung Disease: A Single-Center Retrospective Study. Frontiers in Medicine 8.
Crossref
Crossref
Yimin Li, Yuhui Li, Yuguang Wang, Lianjie Shi, Fuan Lin, Zongxue Zhang, Jingli Zhang, Yanying Liu, Xu Liu, Fangjingwei Xu & Xiaolin Sun. (2021) A Clinical Risk Model to Predict Rapidly Progressive Interstitial Lung Disease Incidence in Dermatomyositis. Frontiers in Medicine 8.
Crossref
Crossref
Koichi Yamaguchi, Aya Yamaguchi, Miki Itai, Yuji Onuki, Yuki Shin, Shogo Uno, Chiharu Hanazato, Kohei Taguchi, Kazue Umetsu, Masaki Aikawa, Shunichi Kouno, Masao Takemura, Kenichiro Hara, Shinsuke Motegi, Mayuko Tsukida, Fumie Ota, Yoshito Tsukada, Mitsuru Motegi, Masao Nakasatomi, Toru Sakairi, Hidekazu Ikeuchi, Yoriaki Kaneko, Keiju Hiromura & Toshitaka Maeno. (2021) Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients. Rheumatology International 41:9, pages 1641-1650.
Crossref
Crossref
Naoko Okano, Nobuteru Kubo, Koichi Yamaguchi, Shunichi Kouno, Yuhei Miyasaka, Tatsuji Mizukami, Katsuyuki Shirai, Jun-ichi Saitoh, Takeshi Ebara, Hidemasa Kawamura, Toshitaka Maeno & Tatsuya Ohno. (2021) Efficacy and Safety of Carbon-Ion Radiotherapy for Stage I Non-Small Cell Lung Cancer with Coexisting Interstitial Lung Disease. Cancers 13:16, pages 4204.
Crossref
Crossref
Kazuki Kagami, Tomonari Harada, Koichi Yamaguchi, Shunichi Kouno, Takahiro Ikoma, Kuniko Yoshida, Toshimitsu Kato, Junichi Tomono, Naoki Wada, Takeshi Adachi, Masahiko Kurabayashi & Masaru Obokata. (2021) Association between lung ultrasound B‐lines and exercise‐induced pulmonary hypertension in patients with connective tissue disease. Echocardiography.
Crossref
Crossref
Wanlong Wu, Li Guo, Yakai Fu, Kaiwen Wang, Danting Zhang, Wenwen Xu, Zhiwei Chen & Shuang Ye. (2021) Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clinical Reviews in Allergy & Immunology 60:2, pages 293-304.
Crossref
Crossref
Takahisa Gono, Kenichi Masui, Naoshi Nishina, Yasushi Kawaguchi, Atsushi Kawakami, Kei Ikeda, Yohei Kirino, Yumiko Sugiyama, Yoshinori Tanino, Takahiro Nunokawa, Yuko Kaneko, Shinji Sato, Katsuaki Asakawa, Taro Ukichi, Shinjiro Kaieda, Taio Naniwa, Yutaka Okano & Masataka Kuwana. (2021) Risk Prediction Modeling Based on a Combination of Initial Serum Biomarker Levels in Polymyositis/Dermatomyositis–Associated Interstitial Lung Disease. Arthritis & Rheumatology 73:4, pages 677-686.
Crossref
Crossref
T. Shimizu, T. Koga, K. Furukawa, Y. Horai, K. Fujikawa, A. Okada, M. Okamoto, Y. Endo, S. Tsuji, A. Takatani, M. Umeda, S. Fukui, R. Sumiyoshi, S.‐y. Kawashiri, N. Iwamoto, T. Igawa, K. Ichinose, M. Tamai, N. Sakamoto, H. Nakamura, T. Origuchi, H. Mukae, M. Kuwana & A. Kawakami. (2020) IL‐15 is a biomarker involved in the development of rapidly progressive interstitial lung disease complicated with polymyositis/dermatomyositis. Journal of Internal Medicine 289:2, pages 206-220.
Crossref
Crossref
Shogo Matsuda, Takuya Kotani, Takayasu Suzuka, Takao Kiboshi, Keisuke Fukui, Minako Wakama, Takaaki Ishida, Youhei Fujiki, Hideyuki Shiba, Koji Nagai, Kenichiro Hata, Takeshi Shoda, Yuri Ito, Shigeki Makino & Tohru Takeuchi. (2021) Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease. Scientific Reports 11:1.
Crossref
Crossref
Rina Takahashi, Tadashi Yoshida, Kohkichi Morimoto, Yasushi Kondo, Jun Kikuchi, Shuntaro Saito, Sho Ishigaki, Yuko Kaneko, Tsutomu Takeuchi, Hiroshi Itoh & Mototsugu Oya. (2021) Successful Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis-Associated Rapidly Progressive-Interstitial Lung Disease by Plasma Exchange: Two Case Reports. Clinical Medicine Insights: Case Reports 14, pages 117954762110363.
Crossref
Crossref
Tomoaki Machiyama, Tsuyoshi Shirai, Yoko Fujita, Hiroko Sato, Hiroshi Fujii, Tomonori Ishii & Hideo Harigae. (2021) Successful concomitant therapy with tofacitinib for anti- melanoma differentiation associated gene 5 antibody-positive rapidly progressive interstitial lung disease with poor prognostic factors. Medicine: Case Reports and Study Protocols 2:1, pages e0026.
Crossref
Crossref
Taisuke Isono, Hiromi Nakajima, Kenji Takano, Yoichi Kobayashi, Yoshinori Kawabata, Yoshihiko Shimizu & Noboru Takayanagi. (2021) Slowly progressive interstitial lung disease preceding typical dermatomyositis symptoms in anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis. Respiratory Medicine Case Reports 34, pages 101491.
Crossref
Crossref
Mirei Shirakashi, Ran Nakashima, Hideaki Tsuji, Kiminobu Tanizawa, Tomohiro Handa, Yuji Hosono, Shuji Akizuki, Kosaku Murakami, Motomu Hashimoto, Hajime Yoshifuji, Koichiro Ohmura & Tsuneyo Mimori. (2020) Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment. Rheumatology 59:11, pages 3284-3292.
Crossref
Crossref
Enrico De Lorenzis, Gerlando Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello & Elisa Gremese. (2020) What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19?. Autoimmunity Reviews 19:11, pages 102666.
Crossref
Crossref
Reiko Wakura, Shogo Matsuda, Takuya Kotani, Takeshi Shoda & Tohru Takeuchi. (2020) The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease. Scientific Reports 10:1.
Crossref
Crossref
Akira Yamagata, Machiko Arita, Ayaka Tanaka, Fumiaki Tokioka, Tomohiro Yoshida, Keisuke Nishimura & Tadashi Ishida. (2020)
Therapeutic plasma exchange for clinically amyopathic dermatomyositis (
CADM
) associated with rapidly progressive interstitial pneumonia
. Journal of Clinical Apheresis 35:5, pages 435-443.
Crossref
Crossref
Yinli Zhang, Yongpeng Ge, Hanbo Yang, He Chen, Xiaolan Tian, Zhenguo Huang, Shengyun Liu, Xin Lu & Guochun Wang. (2020) Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome. Clinical Rheumatology 39:8, pages 2417-2424.
Crossref
Crossref
Yuhui Li, Xiaojuan Gao, Yimin Li, Xiaohui Jia, Xuewu Zhang, Yan Xu, Yuzhou Gan, Shiming Li, Renli Chen, Jing He & Xiaolin Sun. (2020) Predictors and Mortality of Rapidly Progressive Interstitial Lung Disease in Patients With Idiopathic Inflammatory Myopathy: A Series of 474 Patients. Frontiers in Medicine 7.
Crossref
Crossref
Takaaki Ishida, Takuya Kotani, Satoshi Serada, Minoru Fujimoto, Tohru Takeuchi, Shigeki Makino & Tetsuji Naka. (2020) Correlation of increased serum leucine-rich α2-glycoprotein levels with disease prognosis, progression, and activity of interstitial pneumonia in patients with dermatomyositis: A retrospective study. PLOS ONE 15:6, pages e0234090.
Crossref
Crossref
Sonye K. Danoff. 2020. Managing Myositis. Managing Myositis
247
256
.
Koichi Yamaguchi, Aya Yamaguchi, Miki Itai, Chiharu Kashiwagi, Kazutaka Takehara, Shuhei Aoki, Yuri Sawada, Kohei Taguchi, Kazue Umetsu, Kazuma Oshima, Megumi Uchida, Masao Takemura, Kenichiro Hara, Sei-ichiro Motegi, Yoshinao Muro, Masao Nakasatomi, Toru Sakairi, Keiju Hiromura, Masahiko Kurabayashi & Toshitaka Maeno. (2019) Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum. Clinical Rheumatology 38:12, pages 3443-3450.
Crossref
Crossref
Tomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui & Takafumi Suda. (2019) Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody–positive Dermatomyositis-associated Interstitial Lung Disease. The Journal of Rheumatology 46:8, pages 935-942.
Crossref
Crossref
Lili Jiang, Youlian Wang, Qinglin Peng, Xiaoming Shu, Guochun Wang & Xiaomu Wu. (2019) Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody. Clinical Rheumatology 38:6, pages 1655-1663.
Crossref
Crossref
Yumiko Sugiyama, Ryusuke Yoshimi, Maasa Tamura, Mitsuhiro Takeno, Yosuke Kunishita, Daiga Kishimoto, Yuji Yoshioka, Kouji Kobayashi, Kaoru Takase-Minegishi, Toshiyuki Watanabe, Naoki Hamada, Hideto Nagai, Naomi Tsuchida, Yutaro Soejima, Hiroto Nakano, Reikou Kamiyama, Takeaki Uehara, Yohei Kirino, Akiko Sekiguchi, Atsushi Ihata, Shigeru Ohno, Shouhei Nagaoka & Hideaki Nakajima. (2018) The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease. Arthritis Research & Therapy 20:1.
Crossref
Crossref
Kazuhiro Kurasawa, Satoko Arai, Yumeko Namiki, Ayae Tanaka, Yuta Takamura, Takayoshi Owada, Masafumi Arima & Reika Maezawa. (2018) Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology 57:12, pages 2114-2119.
Crossref
Crossref
Anna Ghirardello & Andrea Doria. (2018) New insights in myositis-specific autoantibodies. Current Opinion in Rheumatology 30:6, pages 614-622.
Crossref
Crossref
Toshinori Takada, Kazumasa Ohashi, Masachika Hayashi, Katsuaki Asakawa, Takuro Sakagami, Toshiaki Kikuchi & Shinji Sato. (2018) Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody. Respiratory Medicine 141, pages 7-13.
Crossref
Crossref